Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma

被引：31

作者：

Hong, Kevin Cyrus ^{[1
]}

Schachter, Julius ^{[1
]}

Moncada, Jeanne ^{[1
]}

Zhou, Zhaoxia ^{[1
]}

House, Jenafir ^{[1
]}

Lietman, Thomas M. ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

EMERGING INFECTIOUS DISEASES | 2009年 / 15卷 / 07期

关键词：

INFECTIOUS TRACHOMA; PNEUMONIAE; IMPACT;

D O I：

10.3201/eid1507.081563

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual community-wide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to azithromycin and doxycycline in 6 posttreatment and 4 pretreatment samples.

引用

页码：1088 / 1090

页数：3

共 12 条

[1] IN-VITRO ACTIVITY OF AZITHROMYCIN (CP-62,993) AGAINST CHLAMYDIA-TRACHOMATIS AND CHLAMYDIA-PNEUMONIAE [J].

AGACFIDAN, A ;

MONCADA, J ;

SCHACHTER, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1746-1748

[2] Chlamydial genovar distribution after communitywide antibiotic treatment [J].

Bain, DL ;

Lietman, T ;

Rasmussen, S ;

Kalman, S ;

Fan, J ;

Lammel, C ;

Zhang, JZ ;

Dawson, CR ;

Schachter, J ;

Stephens, RS .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (12) :1581-1588

[3] Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC [J].

Binet, R ;

Maurelli, AT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4455-4464

[4] Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma [J].

Chidambaram, JD ;

Alemayehu, W ;

Melese, M ;

Lakew, T ;

Yi, E ;

House, J ;

Cevallos, V ;

Zhou, ZX ;

Maxey, K ;

Lee, DC ;

Shapiro, BL ;

Srinivasan, M ;

Porco, T ;

Whitcher, JP ;

Gaynor, BD ;

Lietman, TM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10) :1142-1146

[5] Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal [J].

Fry, AM ;

Jha, HC ;

Lietman, TM ;

Chaudhary, JSP ;

Bhatta, RC ;

Elliott, J ;

Hyde, T ;

Schuchat, A ;

Gaynor, B ;

Dowell, SF .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :395-402

[6] Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia [J].

Lakew, Takele ;

House, Jenafir ;

Hong, Kevin C. ;

Yi, Elizabeth ;

Alemayehu, Wondu ;

Melese, Muluken ;

Zhou, Zhaoxia ;

Ray, Kathryn ;

Chin, Stephanie ;

Romero, Emmanuel ;

Keenan, Jeremy ;

Whitcher, John P. ;

Gaynor, Bruce D. ;

Lietman, Thomas M. .

PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (02)

[7] A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae [J].

Leach, AJ ;

ShelbyJames, TM ;

Mayo, M ;

Gratten, M ;

Laming, AC ;

Currie, BJ ;

Mathews, JD .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :356-362

[8]

Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844

[9]

RIPA KT, 1977, J CLIN MICROBIOL, V6, P328

[10] Azithromycin in control of trachoma [J].

Schachter, J ;

West, SK ;

Mabey, D ;

Dawson, CR ;

Bobo, L ;

Bailey, R ;

Vitale, S ;

Quinn, TC ;

Sheta, A ;

Sallam, S ;

Mkocha, H ;

Mabey, D ;

Faal, H .

LANCET, 1999, 354 (9179) :630-635

← 1 2 →